Senores Pharmaceuticals Limited (NSE:SENORES)
832.00
+35.55 (4.46%)
Feb 18, 2026, 1:29 PM IST
Senores Pharmaceuticals Company Description
Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.
It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics, as well as management and consultancy services.
The company was incorporated in 2017 and is based in Ahmedabad, India.
Senores Pharmaceuticals Limited
| Country | India |
| Founded | 2017 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 194 |
| CEO | Swapnil Shah |
Contact Details
Address: South Tower Ahmedabad, Gujarat 380054 India | |
| Phone | 91 79 2999 9857 |
| Website | senorespharma.com |
Stock Details
| Ticker Symbol | SENORES |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE0RB801010 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Swapnil Jatinbhai Shah | MD and Director |
| Deval Rajnikant Shah | Whole-Time Director and Chief Financial Officer |
| Chetan Bipinchandra Shah | Whole-Time Director and Chief Operating Officer |
| Hanuwant Singh Shaktawat | Assistant Vice President of Human Resources and Admin |
| Vinay Kumar Mishra | Company Secretary and Compliance Officer |
| Deepak Jain | Vice President of Regulatory Affairs |
| Jignesh Shashikant Desai | President of Finance |
| Manohar Lalge | President of Research and Development |